|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
PATH Meningitis Vaccine Gets $100M
|
Luke Timmerman |
05/11/11 |
Seattle
|
|
Gates Foundation Dishes Out Latest $100K Grants for ‘Out of the Box’ Global Health Ideas
|
Luke Timmerman |
04/28/11 |
Seattle
|
|
Immune Design Gets New CEO, Seattle Biomed Nabs $9M, VCs Turn Up Heat on FDA, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/28/11 |
Seattle
|
|
Seattle Biomed Nabs $9M Gates Foundation Grant to Speed Up Malaria Vaccine Effort
|
Luke Timmerman |
04/27/11 |
Seattle
|
|
Immune Design, Developer of New Vaccines, Adds Former Elan President as New CEO
|
Luke Timmerman |
04/27/11 |
Seattle
|
|
From Three-Month Ice to Fast Broadband Everywhere: Some Projects You Might Not Know About From Intellectual Ventures Lab
|
Curt Woodward |
04/21/11 |
Seattle
|
|
NanoBio and U-M To Develop Vaccine Against Urinary Tract Infections
|
Thomas Lee |
04/20/11 |
Detroit
|
|
Novartis, Trying Not to Burn the Hamburger, Increases its Bet on the Bay Area
|
Luke Timmerman |
04/19/11 |
San Francisco
|
|
Life Sciences Discovery Fund On Pins and Needles During Budget Talks (Again)
|
Luke Timmerman |
04/14/11 |
Seattle
|
|
Reagent Proteins Unveils E-Commerce Site
|
Bruce V. Bigelow |
03/30/11 |
San Diego
|
|
VBI Progressing with Vaccines That Don’t Require Refrigeration
|
Ryan McBride |
03/24/11 |
Boston
|
|
See You Tonight at Bay Area Life Sciences 2031
|
Luke Timmerman |
03/16/11 |
San Francisco
|
|
Will the Bay Area Still Be the No. 1 Biotech Cluster in 20 Years? We’ll Ask Tomorrow
|
Luke Timmerman |
03/15/11 |
San Francisco
|
|
Alan Aderem, With Team in Tow, Bolts From ISB to Take Leading Role at Seattle BioMed
|
Luke Timmerman |
03/14/11 |
Seattle
|
|
Gates Amps Up Biotech Investment, Calypso Seeks Rebound, Targeted Genetics’ Obit, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
03/10/11 |
Seattle
|
|
Gates Foundation Makes First Equity Investment in a Biotech Startup, Liquidia Technologies
|
Luke Timmerman |
03/08/11 |
Seattle
|
|
Stewart Parker Joins IDRI as New CEO, Bringing Biotech Sensibility to Global Health Effort
|
Luke Timmerman |
02/15/11 |
Seattle
|
|
Tachi Yamada, Gates Foundation’s Global Health Leader, Stepping Down in June
|
Luke Timmerman |
02/14/11 |
Seattle
|
|
Genocea Announces New CEO, Pfizer to Add Jobs In MA, Ocular Raises $14M, and More Boston-Area Life Sciences News
|
Erin Kutz |
02/04/11 |
Boston
|
|
Genocea Biosciences Names New CEO
|
Ryan McBride |
02/01/11 |
Boston
|
|
Top Trends to Watch in 2011 From Experts in Infotech, Biotech, Cleantech
|
Luke Timmerman |
01/19/11 |
National
|
|
Vaccine Innovations That Will Expedite Access for the Next Generation of Treatments
|
James Baker, Jr. |
01/04/11 |
Detroit
|
|
Genocea Biosciences Raises $35M from J&J and Others for Vaccines Business
|
Ryan McBride |
01/03/11 |
Boston
|
|
Vaccines Top the List of 2010 Innovations
|
Larry Corey |
12/27/10 |
Seattle
|
|
PacBio, Harvard Use Fast Gene Sequencer to Crack DNA Code of Haitian Cholera Strain
|
Luke Timmerman |
12/09/10 |
San Francisco
|
|
Seattle Genetics’ Home Run, NanoString’s Diagnostics Foray, PATH’s 50-Cent Vaccine, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
12/09/10 |
Seattle
|
|
Hutch Snaps Up $5.6M at Holiday Gala
|
Luke Timmerman |
12/08/10 |
Seattle
|
|
Watch Out Big Pharma: PATH, WHO Show that Nonprofits Can Develop New Meningitis Vaccine
|
Luke Timmerman |
12/08/10 |
Seattle
|
|
Accelerator’s East Coast Foray, Gates Foundation Bets on RSV Vaccine, UW Sues GE, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
12/02/10 |
Seattle
|
|
NanoBio Nabs $6M from Gates Foundation for Nasal Spray Vaccine
|
Luke Timmerman |
11/30/10 |
Detroit
|
|
Page 2 of
8 |
« previous page · next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.